Complex Injectables

Our capabilities in Complex Injectables include developing and manufacturing products with complex active pharmaceutical ingredients (APIs), advanced formulations, specialized routes of administration, and drug-device combinations.

With an expertise in complex injectable technologies, we work with liposomes, nanoparticles, nanosuspensions, nanoemulsions, microspheres, peptides, and complex APIs under GMP-compliant manufacturing conditions.

Our portfolio includes a range of advanced injectable formulations such as liposomal products, nanoparticle and nanosuspension-based systems, nanoemulsions, and microsphere-based injectables. These technologies are designed to address formulation and delivery challenges associated with complex molecules, biologics, and poorly soluble drugs.

Complex injectable technologies offer several advantages over conventional drug delivery systems, such as-

• Controlled drug delivery
• Accurate dosing
• Enhanced efficacy and safety
• Site-specific delivery
• Reduced toxicity and side effects
• Improved patient compliance.

Advanced delivery platforms such as suspensions and lipid-based nanoparticles also support improved bioavailability, stability, and long-acting drug delivery.

We are striving to develop high-quality, scalable, and reliable injectable solutions that address evolving therapeutic and patient needs across global markets.